MOYES JAY M

CIK 00011910628 companiesCOLUMBIA, MD

SEC Profile

Transactions

Companies

Filings

CIK

0001191062

Recent Transactions

50 trades

Award
BioCardia, Inc.$BCDA
Stock Option (right to buy)
2025-12-08+12,000→ 15,573 total
Purchase
Sintx Technologies, Inc.$SINT
Common Stock
2025-08-26$3.59/sh+3,000→ 3,000 total
Sale
PUMA BIOTECHNOLOGY, INC.$PBYI
Common Stock
2025-06-13$3.40/sh−22,000→ 53,322 total
Award
PUMA BIOTECHNOLOGY, INC.$PBYI
Common Stock
2025-06-11+27,000→ 75,322 total
Award
BioCardia, Inc.$BCDA
Stock Option (right to buy)
2024-10-11+829→ 3,573 total
Award
PUMA BIOTECHNOLOGY, INC.$PBYI
Common Stock
2024-06-18+27,000→ 48,322 total
Sale
PUMA BIOTECHNOLOGY, INC.$PBYI
Common Stock
2024-06-13$3.34/sh−22,000→ 21,322 total
Award
BioCardia, Inc.$BCDA
Stock Option (right to buy)
2023-10-18+12,434→ 41,233 total
Sale
PUMA BIOTECHNOLOGY, INC.$PBYI
Common Stock
2023-06-13$3.45/sh−22,000→ 16,322 total
Award
PUMA BIOTECHNOLOGY, INC.$PBYI
Common Stock
2023-06-13+27,000→ 43,322 total
Award
SERA PROGNOSTICS, INC.$SERA
Stock Option (right to buy)
2023-03-06+51,800→ 51,800 total
Award
SERA PROGNOSTICS, INC.$SERA
Class A Common Stock
2023-03-06+32,800→ 35,630 total
Sale
PUMA BIOTECHNOLOGY, INC.$PBYI
Common Stock
2022-06-16$2.64/sh−22,858→ 38,322 total
Award
PUMA BIOTECHNOLOGY, INC.$PBYI
Common Stock
2022-06-14+27,000→ 61,180 total
Award
BioCardia, Inc.$BCDA
Stock Option (right to buy)
2022-06-10+12,434→ 28,789 total
Award
ACHIEVE LIFE SCIENCES, INC.$ACHV
Stock Option (right to buy)
2022-05-31+4,400→ 4,400 total
Award
SERA PROGNOSTICS, INC.$SERA
Stock Option (right to buy)
2022-03-23+168,275→ 168,275 total
Conversion
SERA PROGNOSTICS, INC.$SERA
Series A-2 Preferred Stock
2021-07-19−2,455→ 0 total
Conversion
SERA PROGNOSTICS, INC.$SERA
Class A Common Stock
2021-07-19+2,455→ 2,455 total
Conversion
SERA PROGNOSTICS, INC.$SERA
Series B-1 Preferred Stock
2021-07-19−375→ 0 total
Conversion
SERA PROGNOSTICS, INC.$SERA
Class A Common Stock
2021-07-19+375→ 2,830 total
Award
BioCardia, Inc.$BCDA
Stock Option (right to buy)
2021-06-15+12,434→ 16,355 total
Award
PUMA BIOTECHNOLOGY, INC.$PBYI
Common Stock
2021-06-15+27,858→ 34,180 total
Sale
PUMA BIOTECHNOLOGY, INC.$PBYI
Common Stock
2021-06-10$11.36/sh−25,248→ 6,322 total
Award
ACHIEVE LIFE SCIENCES, INC.$ACHV
Stock Option (right to buy)
2021-05-11+3,750→ 3,750 total
Award
BioCardia, Inc.$BCDA
Common Stock
2021-03-31+3,456→ 54,267 total
Award
BioCardia, Inc.$BCDA
Common Stock
2020-12-31+2,800→ 47,061 total
Award
BioCardia, Inc.$BCDA
Common Stock
2020-12-31+3,750→ 50,811 total
Award
BioCardia, Inc.$BCDA
Common Stock
2020-09-30+3,750→ 44,261 total
Sale
PUMA BIOTECHNOLOGY, INC.$PBYI
COMMON STOCK
2020-09-16$10.00/sh−9,703→ 31,570 total
Award
BioCardia, Inc.$BCDA
Common Stock
2020-06-30+3,750→ 40,511 total
Sale
PUMA BIOTECHNOLOGY, INC.$PBYI
COMMON STOCK
2020-06-16$9.50/sh−9,720→ 41,273 total
Award
PUMA BIOTECHNOLOGY, INC.$PBYI
COMMON STOCK
2020-06-09+25,748→ 50,993 total
Award
ACHIEVE LIFE SCIENCES, INC.$ACHV
Stock Option (right to buy)
2020-05-12+22,000→ 22,000 total
Award
BioCardia, Inc.$BCDA
Common Stock
2020-05-08+8,800→ 36,761 total
Award
BioCardia, Inc.$BCDA
Common Stock
2020-04-30+3,750→ 27,961 total
Award
BioCardia, Inc.$BCDA
Common Stock
2020-04-30+20,250→ 24,211 total
Exercise/Conversion
BioCardia, Inc.$BCDA
Common Stock
2019-07-26+3,594→ 3,961 total
Exercise/Conversion
BioCardia, Inc.$BCDA
Restricted Stock Units
2019-07-26−3,594→ 0 total
Award
PUMA BIOTECHNOLOGY, INC.$PBYI
COMMON STOCK
2019-06-10+19,423→ 25,245 total
Award
ACHIEVE LIFE SCIENCES, INC.$ACHV
Stock Option (right to buy)
2019-05-14+7,000→ 7,000 total
Award
ACHIEVE LIFE SCIENCES, INC.$ACHV
Stock Option (right to buy)
2018-09-20+12,000→ 12,000 total
Award
BioCardia, Inc.$BCDA
Restricted Stock Units
2018-07-26+32,353→ 32,353 total
Award
PUMA BIOTECHNOLOGY, INC.$PBYI
COMMON STOCK
2018-06-12+5,822→ 5,822 total
Award
ACHIEVE LIFE SCIENCES, INC.$ACHV
Stock Option (right to buy)
2017-08-01+16,400→ 16,400 total
Award
ACHIEVE LIFE SCIENCES, INC.$ACHV
Stock Option (right to buy)
2017-08-01+16,400→ 16,400 total
Award
BioCardia, Inc.$BCDA
Director Stock Option (right to buy)
2017-06-15+156,583→ 156,583 total
Award
PUMA BIOTECHNOLOGY, INC.$PBYI
Stock Option (Right to Buy)
2017-06-12+7,604→ 7,604 total
Award
BioCardia, Inc.$BCDA
Director Stock Option (right to buy)
2017-01-13+267,000→ 267,000 total
Award
PUMA BIOTECHNOLOGY, INC.$PBYI
Stock Option (Right to Buy)
2016-11-14+10,000→ 10,000 total

Companies

Recent Filings

Address

C/O OSIRIS THERAPEUTICS, INC. 7015 ALBERT EINSTEIN DRIVE

COLUMBIA, MD, 21046

View on SEC.gov